Sitagliptin Accord Unione Europea - italiano - EMA (European Medicines Agency)

sitagliptin accord

accord healthcare s.l.u. - sitagliptin hydrochloride - diabete mellito, tipo 2 - farmaci usati nel diabete - for adult patients with type 2 diabetes mellitus, sitagliptin accord is indicated to improve glycaemic control:as monotherapy:- in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance. as dual oral therapy in combination with:- metformin when diet and exercise plus metformin alone do not provide adequate glycaemic control. - a sulphonylurea when diet and exercise plus maximal tolerated dose of a sulphonylurea alone do not provide adequate glycaemic control and when metformin is inappropriate due to contraindications or intolerance. - a peroxisome proliferator-activated receptor gamma (ppary) agonist (i. a thiazolidinedione) when use of a ppary agonist is appropriate and when diet and exercise plus the ppary agonist alone do not provide adequate glycaemic control. as triple oral therapy in combination with:- a sulphonylurea and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. - a ppary agonist and metformin when use of a ppary agonist is appropriate and when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. sitagliptin accord is also indicated as add-on to insulin (with or without metformin) when diet and exercise plus stable dose of insulin do not provide adequate glycaemic control.

GEMFIBROZIL RATIO. 20CPR 900MG Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

gemfibrozil ratio. 20cpr 900mg

ratiopharm italia srl - gemfibrozil - compresse - "900 mg compresse" 20 compresse

BACTRIM Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

bactrim

eumedica pharmaceuticals gmbh - associazioni di sulfamidici con trimetoprim, inclusi i derivati - associazioni di sulfamidici con trimetoprim, inclusi i derivati

CITILAT Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

citilat

laboratorio farmaceutico c.t. s.r.l. - derivati diidropiridinici - derivati diidropiridinici

CORAL Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

coral

s.f. group s.r.l. - nifedipina - nifedipina

RIFINAH Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

rifinah

sanofi s.r.l. - rifampicina, associazioni - rifampicina, associazioni

LOPID Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

lopid

pfizer italia s.r.l. - gemfibrozil - gemfibrozil